ALB
ALBEMARLE CORP
NYSE · Basic Materials · Chemicals - Specialty · US
$102.75
−3.39%Year over year
Reported trailing growth
- Revenue
- +18.3%
- EBITDA
- +113.3%
- EBIT
- +413.9%
- EPS
- +105.1%
- Free cash flow
- +787.9%
- Operating cash flow
- +135.0%
Forward estimates
Based on analyst estimates
- Revenue
- +0.3%
- EBITDA
- +144.5%
- EPS
- +1924.4%
Three-year CAGR
- Revenue
- -11.1%
- EBITDA
- -46.4%
- EBIT
- -66.5%
- Net income
- +56.7%
- EPS
- +48.7%
- Free cash flow
- +2.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026